Aquestive Therapeutics Inc. (AQST) Misses Q4 EPS by 6c

Aquestive Therapeutics Inc. (NASDAQ: AQST) reported Q4 EPS of ($0.19), $0.06 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $11.87 million versus the consensus estimate of $13.08 million.

For earnings history and earnings-related data on Aquestive Therapeutics Inc. (AQST) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c